RTI Surgical® has reached a truly remarkable milestone; providing 8 million biologic implants processed through their proprietary sterilisation processes with zero confirmed incidence of implant-associated infection.
RTI Surgical® celebrates this milestone as it marks its 20th Anniversary of Tissue Banking; helping distribute over 600,000 trusted surgical implants to nearly 50 countries worldwide in 2017 alone.
They are recognised for initiating and elevating standards for the tissue banking industry, including being the first to introduce tissue-specific validated sterilisation processes — the BioCleanse® Tissue Sterilisation Process, the Cancelle® SP DBM Sterilisation Process and the Tutoplast® Tissue Sterilisation Process. They were also the first to offer precision-shaped bone implants and assembled technologies.
Hospital Innovations is proud to work with RTI Surgical®; a true pioneer of biological implants.Back